Citius Pharmaceuticals Inc. (NASDAQ: CTXR) Starts Presentation at NobleCon16
Citius Pharmaceuticals (NASDAQ: CTXR) is a specialty pharmaceutical company dedicated to the development and commercialization of critical care products, focusing on anti-infectives, cancer care and unique prescription products that use innovative, patented or proprietary formulations of previously-approved active pharmaceutical ingredients. The company seeks to achieve leading market positions by providing therapeutic products that address unmet medical needs, using previously approved drugs with substantial safety and efficacy data to reduce the risks associated with pharmaceutical product development and regulatory requirements. Citius develops products that have intellectual property protection and competitive advantages to existing therapeutic approaches. For more information, visit the company’s…







